Resolution Minerals Ltd (RML.AX) Investor Webinar
Adelaide, July 4, 2025 AEST (ABN Newswire) - Resolution Minerals Ltd (
ASX:RML) (
NC3:FRA) (
RLMLF:OTCMKTS) is pleased to invite shareholders and investors to an Investor Webinar where management will provide a Company update on the recent ASX Announcements.
- Acquisition of the Horse Heaven Gold-Antimony-Tungsten Project which is adjacent to the Perpetua Resources Corp. (PPTA.NAS) Stibnite Gold Mine
- Dual listing expected to expedite growth and unlock value for existing Australian and new U.S. shareholders through the OTCQB Markets listing (ticker: RLMLF)
- Appointment of Clewett Global Services as external affairs advisers to support the development of the Horse Heaven Antimony-Gold-Silver-Tungsten project in Idaho, USA
- Appointment of Austin Zinsser, a former Senior Resource Geologist and in exploration and development roles on NASDAQ-listed Perpetua Resources' (PPTA.NAS)
- Commencement of the maiden exploration program at the Horse Heaven Gold-Silver-Tungsten Project in Idaho, USA.
The webinar details are as follows:
Date: Monday 7 July 2025
Time: 11:00am AEST / 9:00am AWST
Registration Link:
https://www.abnnewswire.net/lnk/588ZOZ1C
Participants will be able to submit questions via the Panel throughout the presentation; however, we highly encourage attendees to send through questions via email beforehand to info@janemorganmanagement.com.au
About Resolution Minerals Ltd
Resolution Minerals Ltd (ASX:RML) is a mineral exploration company engaged in the acquisition, exploration and development of precious and battery metals - such as antimony, gold, copper, and uranium.
Resolution Minerals Ltd Listed on the ASX in 2017 and has a broad portfolio of assets, such as the Drake East Antimony-Gold Project in north-eastern NSW and George Project prospective for silica sand and uranium.
Related Companies
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
